These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26808648)

  • 1. Beyond efficacy: The full public health impact of vaccines.
    Saadatian-Elahi M; Horstick O; Breiman RF; Gessner BD; Gubler DJ; Louis J; Parashar UD; Tapia R; Picot V; Zinsou JA; Nelson CB
    Vaccine; 2016 Feb; 34(9):1139-47. PubMed ID: 26808648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The public health value of vaccines beyond efficacy: methods, measures and outcomes.
    Wilder-Smith A; Longini I; Zuber PL; Bärnighausen T; Edmunds WJ; Dean N; Spicher VM; Benissa MR; Gessner BD
    BMC Med; 2017 Jul; 15(1):138. PubMed ID: 28743299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the full public health value of vaccination.
    Gessner BD; Kaslow D; Louis J; Neuzil K; O'Brien KL; Picot V; Pang T; Parashar UD; Saadatian-Elahi M; Nelson CB
    Vaccine; 2017 Nov; 35(46):6255-6263. PubMed ID: 28986035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From the licensure of vaccines to the recommendation of the Standing Committee on Vaccination in Germany : criteria for the assessment of benefits and risks].
    Pfleiderer M; Wichmann O
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Mar; 58(3):263-73. PubMed ID: 25566841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The costs and effectiveness of large Phase III pre-licensure vaccine clinical trials.
    Black S
    Expert Rev Vaccines; 2015; 14(12):1543-8. PubMed ID: 26414015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine preventable disease incidence as a complement to vaccine efficacy for setting vaccine policy.
    Gessner BD; Feikin DR
    Vaccine; 2014 May; 32(26):3133-8. PubMed ID: 24731817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine-Preventable Disease Incidence Based on Clinically, Radiologically, and Etiologically Confirmed Outcomes: Systematic Literature Review and Re-analysis of Pneumococcal Conjugate Vaccine Efficacy Trials.
    Bollaerts K; Fletcher MA; Suaya JA; Hanquet G; Baay M; Gessner BD
    Clin Infect Dis; 2022 Apr; 74(8):1362-1371. PubMed ID: 34313721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines as a tool to estimate the burden of severe influenza in children of low-resourced areas (November 30-December 1, 2012, Les Pensieres, Veyrier-du-Lac, France).
    Gessner BD; Brooks WA; Neuzil KM; Vernet G; Bright RA; Tam JS; Bresee J; Monto AS
    Vaccine; 2013 Jul; 31(32):3222-8. PubMed ID: 23707161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines.
    Lopalco PL; DeStefano F
    Vaccine; 2015 Mar; 33(13):1541-8. PubMed ID: 25444788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the public health importance of the CYD-tetravalent dengue vaccine: Vaccine preventable disease incidence and numbers needed to vaccinate.
    Gessner BD; Wilder-Smith A
    Vaccine; 2016 Apr; 34(20):2397-401. PubMed ID: 27055020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live-attenuated tetravalent dengue vaccines: The needs and challenges of post-licensure evaluation of vaccine safety and effectiveness.
    Wichmann O; Vannice K; Asturias EJ; de Albuquerque Luna EJ; Longini I; Lopez AL; Smith PG; Tissera H; Yoon IK; Hombach J
    Vaccine; 2017 Oct; 35(42):5535-5542. PubMed ID: 28893477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the safety of new vaccines: summary of a workshop.
    Ellenberg SS; Foulkes MA; Midthun K; Goldenthal KL
    Am J Public Health; 2005 May; 95(5):800-7. PubMed ID: 15855455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel licensure pathways for expeditious introduction of new tuberculosis vaccines: a discussion of the adaptive licensure concept.
    Rustomjee R; Lockhart S; Shea J; Fourie PB; Hindle Z; Steel G; Hussey G; Ginsberg A; Brennan MJ
    Tuberculosis (Edinb); 2014 Mar; 94(2):178-82. PubMed ID: 24360811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.
    Boily MC; Abu-Raddad L; Desai K; Masse B; Self S; Anderson R
    Lancet Infect Dis; 2008 Mar; 8(3):200-7. PubMed ID: 18291341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principles of Vaccine Licensure, Approval, and Recommendations for Use.
    Pickering LK; Meissner HC; Orenstein WA; Cohn AC
    Mayo Clin Proc; 2020 Mar; 95(3):600-608. PubMed ID: 32063358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the impact of pneumococcal vaccines on nasopharyngeal carriage to aid licensing and vaccine implementation; a PneumoCarr meeting report March 27-28, 2012, Geneva.
    Goldblatt D; Ramakrishnan M; O'Brien K
    Vaccine; 2013 Dec; 32(1):146-52. PubMed ID: 23933374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines for preventing influenza in healthy children.
    Jefferson T; Rivetti A; Di Pietrantonj C; Demicheli V; Ferroni E
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD004879. PubMed ID: 22895945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine Development: From Laboratory to Policy.
    Park HS; Samuels EL; Bocchini JA
    Pediatr Ann; 2020 Dec; 49(12):e509-e515. PubMed ID: 33290568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.